A new PanCAN-authored paper uses feedback provided by patients with pancreatic cancer to identify trends in reporting pain.

The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to [...] READ MORE ...

Pancreatic cancer patients who participate in clinical research have better outcomes. Learn more and search our up-to-date clinical trials database.

NEW − You Helped Secure More Support of Increased Research Funding! You helped the pancreatic cancer community take a big step forward in securing increased federal funding for research! Thanks to ...

Guiding the Pancreatic Cancer Community - Pancreatic Cancer Action Network*PanCAN’s Case Managers are not medical or nutritional professionals and are therefore unable to provide medical/nutritional ...

American Cancer Society’s Cancer Facts & Figures 2023 reports that the five-year survival rate for pancreatic cancer has increased to 12%, progress that PanCAN’s initiatives helped to fuel.

They are orange, they are flavorful and packed-full of nutrition – sweet potatoes are sure to add a pop of color to your plates in the upcoming holiday season. These root vegetables are available year ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...

Learn about the common symptoms of the world’s toughest cancer, such as weight loss, digestive problems, back pain and more.

Leading Nonprofit Highlights the Importance of Early Detection on World Pancreatic Cancer Day For Full Survey Results, click HERE LOS ANGELES, Calif. (November 17, 2022) – A new survey commissioned by ...

For the first time in more than 10 years, the FDA has approved a new first-line treatment, called NALIRIFOX, for patients with metastatic pancreatic cancer.